- US-listed companies
- AMGEN INC
- Cash flow
AMGEN INCAMGN
Market cap
$175.3B
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 1,017 | 1,060 | 1,088 | 1,286 | 2,092 | 2,108 | 2,105 | 1,955 | 1,946 | 2,206 | 3,601 | 3,398 | 3,417 | 4,071 | 5,592 |
| Stock-based compensation | 353 | 341 | 362 | 403 | 408 | 322 | 311 | 329 | 311 | 308 | 330 | 341 | 401 | 431 | 530 |
| Cash from operations | 5,787 | 5,119 | 5,882 | 6,291 | 8,555 | 9,077 | 10,354 | 11,177 | 11,296 | 9,150 | 10,497 | 9,261 | 9,721 | 8,471 | 11,490 |
| Capital expenditures | -580 | -567 | -689 | -693 | -718 | -594 | -738 | -664 | -738 | -618 | -608 | -880 | -936 | -1,112 | -1,096 |
| Cash from investing | -4,152 | -786 | -9,990 | -8,469 | -5,752 | -5,547 | -8,658 | -4,024 | 14,339 | 5,709 | -5,401 | 733 | -6,044 | -26,204 | -1,046 |
| Repurchases of common stock | 3,786 | 8,315 | 4,607 | 832 | 138 | 1,867 | 2,965 | 3,160 | 17,794 | 7,702 | 3,486 | 4,975 | 6,360 | - | 200 |
| Proceeds from issuance of term debt, net | 2,471 | 10,387 | 4,933 | 8,054 | 4,476 | 3,465 | 7,318 | 4,476 | - | - | 8,914 | 4,945 | 6,919 | 27,777 | - |
| Repayments of term debt | - | 2,500 | 123 | 3,371 | 5,605 | 2,400 | 3,700 | 4,405 | 1,121 | 4,500 | 6,450 | 4,150 | - | 1,454 | 3,600 |
| Cash from financing | -1,232 | -674 | 419 | 2,726 | -2,877 | -3,117 | -2,599 | -6,594 | -22,490 | -15,767 | -4,867 | -8,271 | -4,037 | 21,048 | -9,415 |
| Free cash flow | |||||||||||||||
| FCF margin (%) |